Rights offering: final issue price set

What happened

Clobot / Rights Offering: Final Issue Price Set / (2026.08.11) Rights Offering: Final Issue Price Set

Rights Offering: Final Issue Price Set

1. Planned issuance details a. Type of stock: Clobot Co., Ltd. registered common stock b. Number of shares: 5,494,500

2. Final issue price (per share) a. Final price (KRW): 20,600 b. First issue price (KRW): 20,600 c. Second issue price (KRW): 23,900

3. Par value (KRW): 500

4. Final determination date: 2026-08-10

5. Other matters material to investment decisions

Calculation of the final issue price Pursuant to Article 5-18 (Determination of the Issue Price for Rights Offerings) of the Regulation on Issuance and Disclosure of Securities, discount rates etc. for shareholder-allotment and shareholder-priority public-offering capital increases have been liberalized so that the issue price may be freely determined; however, in light of concerns about market disruption and existing practice, the issue price is determined by applying, in part, the method under Article 57 of the (former) Regulation on Issuance and Disclosure of Securities, etc.

(1) Calculation of the first issue price: Taking the 3rd trading day before the new-share allotment record date as the base date, the lower of (i) the arithmetic average of the 1-month volume-weighted average price, the 1-week volume-weighted average price (each weighted by trading value over trading volume on the KOSDAQ market) and the closing price on the base date, and (ii) the closing price on the base date, is taken as the reference price; a discount rate of 25% is applied to this reference price, and the first issue price is calculated by the following formula. Amounts below the quotation unit are rounded up, and if the per-share issue price is below par value, par value is used. First issue price = Reference price x (1 - discount rate) / [1 + (capital-increase ratio x discount rate)]

(2) Calculation of the second issue price: Taking the 3rd trading day before the existing shareholders' subscription date as the base date, the lower of (i) the arithmetic average of the 1-week volume-weighted average price on the KOSDAQ market and the closing price on the base date, and (ii) the closing price on the base date, has the same discount rate (25%) applied, and the second issue price is calculated by the following formula. Amounts below the quotation unit are rounded up, and if the per-share issue price is below par value, par value is used. Second issue price = Reference price x (1 - discount rate)

(3) Calculation of the final issue price: The final issue price is the lower of (i) the first issue price above and (ii) the second issue price above. However, pursuant to Article 165-6 of the Financial Investment Services and Capital Markets Act and Article 5-15-2 of the Regulation on Issuance and Disclosure of Securities, if the price calculated by applying a 40% discount rate to the volume-weighted average price from the 3rd to the 5th trading day before the subscription date exceeds the lower of the first and second issue prices, that amount becomes the final issue price. (Amounts below the quotation unit are rounded up.)

(4) Disclosure of the finalized offering price: The first issue price was determined on the 3rd trading day before the new-share allotment record date (July 2, 2026) and disclosed on the Financial Supervisory Service's electronic disclosure system (DART) on July 3, 2026; the final issue price was determined on the 3rd trading day before the existing shareholders' subscription date (August 10, 2026) and is scheduled to be disclosed on DART on August 11, 2026, with notice given on the company's website (http://clobot.co.kr), as provided in the articles of incorporation, in lieu of individual notice. An amendment report (confirmation of securities issuance terms) will be disclosed on DART following the determination of the final issue price.

* The general public offering issue price applies the same final issue price as applied to the existing shareholders' subscription.

Related disclosure: -